Compare ETFs: LABU
LABU
Comparison
Average Return
| Symbol | Year-to-date | 1 Year | 5 Years | 10 Years | Inception |
|---|---|---|---|---|---|
| LABU | -48.98% | -57.36% | -44.67% | - | -34.35% |
Top 25 Holdings
| LABU - Direxion Daily S&P Biotech Bull 3X Shares | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | n/a | Goldman Sachs Sterling FixInc Port Inc | 21.20% |
| 2 | n/a | Dreyfus Govt Cash Man Ins | 19.02% |
| 3 | n/a | Dreyfus Trsry Securities Cash Mgmt | 7.58% |
| 4 | n/a | Goldman Sachs Fin Gov 465 Institut | 4.00% |
| 5 | n/a | S&P Biotechnology Select Industry Index Swap | 3.99% |
| 6 | n/a | Cash | 1.96% |
| 7 | EXAS | Exact Sciences Corporation | 1.95% |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.89% |
| 9 | NBIX | Neurocrine Biosciences, Inc. | 1.87% |
| 10 | NTRA | Natera, Inc. | 1.85% |
| 11 | UTHR | United Therapeutics Corporation | 1.71% |
| 12 | BPMC | Blueprint Medicines Corporation | 1.56% |
| 13 | INSM | Insmed Incorporated | 1.55% |
| 14 | GILD | Gilead Sciences, Inc. | 1.54% |
| 15 | INCY | Incyte Corporation | 1.52% |
| 16 | ABBV | AbbVie Inc. | 1.52% |
| 17 | BIIB | Biogen Inc. | 1.50% |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 1.50% |
| 19 | AMGN | Amgen Inc. | 1.49% |
| 20 | REGN | Regeneron Pharmaceuticals, Inc. | 1.41% |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.41% |
| 22 | EXEL | Exelixis, Inc. | 1.33% |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 1.26% |
| 24 | MRNA | Moderna, Inc. | 1.24% |
| 25 | HALO | Halozyme Therapeutics, Inc. | 1.16% |
| View LABU holdings | |||